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Abstract
Background: Anti-inflammatory drugs, NSAIDs, have become an important part of the pain
management in day surgery. The aim of the present study was to evaluate the effect of Coxib
premedication on the intra-operative anaesthetic requirements in patients undergoing elective
ankle surgery in general anaesthesia.
Type of study: Prospective, randomized study of the intra-operative anaesthetic-sparing effects
of etoricoxib premedication as compared to no NSAID preoperatively.
Methods: The intra-operative requirement of sevoflurane was studied in forty-four ASA 1–2
patients undergoing elective ankle day surgical in balanced general anaesthesia.
Primary study endpoint was end-tidal sevoflurane concentration to maintain Cerebral State Index
of 40 – 50 during surgery.
Results: All anaesthesia and surgery was uneventful, no complications or adverse events were
noticed. The mean end-tidal sevoflurane concentration intra-operatively was 1.25 (SD 0.2) and 0.91
(SD 0.2) for the pre and post-operative administered group of patients respectively (p < 0.0001).
No other intra-operative differences could be noted. Emergence and recovery was rapid and no
difference was noticed in time to discharge-eligible mean 52 minutes in both groups studied. In all
6 patients, 5 in the group receiving etoricoxib post-operatively, after surgery, and one in the pre-
operative group required rescue analgesia before discharge from hospital. No difference was seen
in pain or need for rescue analgesia, nausea or patients satisfaction during the first 24 postoperative
hours.
Conclusion: Coxib premedication before elective day surgery has an anaesthetic sparing potential.
Background
Multi modal postoperative pain management has become
standard of care especially in day case surgery [1]. Local
anaesthesia applied prior to incision has been shown to
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but also to reduce the needs for main anaesthetic [2-4].
The effects of pre-treatment, premedication with NSAIDs
as well as pre-incisional local anaesthesia have convinc-
ingly been shown to have a major impact on the postop-
erative pain course [5]. We found, in a previous study, pre-
incisional local anaesthesia to have also clear intra-opera-
tive anaesthetic sparing effects [4]. The intra-operative
effects, the effects on the main anaesthetic requirement, of
preoperative administration of a Coxibs are, however, not
well studied. Hypothetically administration of Coxibs
preoperatively could have intra-operative effects by its
prostaglandin inhibitory effect and thereby additive anal-
gesic effects reducing the need for main anaesthetic.
The aim of the present study was to evaluate the effects of
adding a Coxib pre-operatively on the need for main
anaesthetic during balanced anaesthesia for elective day
surgery.
Methods
After informed consent 44 healthy American Society of
Anesthesiology physiological status 1–2 patients; healthy
patients aged 18 to 70 years scheduled for elective ankle
surgery in general anaesthesia, as day cases, were eligible
for inclusion. Patients with history of any previous reac-
tion to NSAIDs or Coxibs, renal disease, not fully control-
led cardiovascular disease or psychiatric disease requiring
Litium therapy were excluded. Seventeen males and 27
females; mean age 45 (SD 14) years, mean weight 80 (SD
15) was included.
The study protocol, a prospective randomised study of the
effects of pre-operative administration of a Coxib on the
intra-operative anaesthetic requirements during elective
day surgery was approved by ethical board at Karolinska
Institut in Stockholm.
Primary study end-point: mean end-tidal sevoflurane con-
centration during surgery to maintain a Cerebral State
index 40 – 50.
Secondary study variables;
• Need for rescue analgesics during recovery




The patients were randomised into two groups by compu-
ter prepared randomisation;
• Group A had etoricoxib 120 mg oral pre-surgery – pre-
operative group
• Group B had etoricoxib 120 mg oral right after end-of-
surgery – postoperative group
All patients followed the routine pre and postoperative
protocol of our institution.
They were asked to refrain from eating for 6 hours and
drinking for 2 hour prior to surgery.
After establishment of an intravenous line all patients
were given 8 mg betamethasone, and a sedation dose of
30 – 40 mg propofol; washing and dressing while sedated.
Two electrodes were applied on the forehead and one on
the masteoid in accordance to the instructions for Cere-
bral State Monitor. The Cerebral State Index (CSI) derived
from a Cerebral State Monitor (Danmeter A/S, Kildemo-
sevej 13, DK-5000 Odense C, Denmark) was followed
during the entire procedure.
All patients had induction of anaesthesia with a combina-
tion of 8–9 μg/kg alfentanil as a iv. injection and propofol
sufficient to allow insertion of a laryngeal mask airway.
All patients were breathing spontaneous; no muscle relax-
ant was given.
Right after insertion of the laryngeal mask sevoflurane in
oxygen/air 1 L/min was introduced as main anaesthetic.
During surgery a CSI of 40 – 50 was set as adequate depth
of anaesthesia. The Sevoflurane was titrated aiming for a
Cerebral State Index of 40 – 50 throughout surgery; the
vaporizer setting was increased to 8% if signs of light
anaesthesia and decreased stepwise by 2% if signs of
excessive anaesthesia. Any other signs of inadequate or
excessive anaesthesia by means of changes in heart rate,
blood pressure or movements were also acknowledged.
During wound close sevoflurane was discontinued and
fresh gas flows were increased. All patients had local
anaesthesia (bupivacaine 5 mg/ml 10 cc) in the wound
area at end of surgery cc infiltrated in open surgery and
injected in to the joint in arthroscopy patients in accord-
ance to the routine of the department.
Cerebral State Index, end-tidal sevoflurane concentra-
tions, heart rate, systolic blood pressure and respiratory
rate were recorded every 3rd minute during surgery. Mean
end-tidal sevoflurane concentration during maintenance
of anaesthesia was calculated as primary study variable.
Immediately after surgery all patients were moved to the
recovery area, if fully awake and alert an Observer Assess-
ment of Sedation Score of 5, possibly bypassing conven-Page 2 of 6
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patients had an initial oral loading dose of 30 mg/kg para-
cetamol in accordance to the routines of the department.
The postoperative group was together with the paraceta-
mol given 120 mg etoricoxib orally; in the pre-operative
group no further analgesics were given. Rescue analgesia,
oxicodone orally, was provided in case patient graded
pain on a 4 graded scale; no pain, mild pain, pain, severe
pain. Patients were discharged when awake, and ambu-
lant with minimal and acceptable levels of subjective pain
(no/mild pain) in accordance with the standardised pro-
tocol of the institution.
At discharge all patients were provided with dextropro-
poxyphene 100 mg as oral rescue analgesic. All patients
were also asked to fill in a postoperative questionnaire
about pain, need for rescue analgesia, emesis, sleep distur-
bance and overall pain treatment satisfaction.
Statistics
All values are given as mean and standard deviation. End-
tidal concentration during maintenance and all other con-
tinuous data was compared between groups by ANOVA,
differences in category data was analysed by Chi-Square
test, and a p < 0.05 was considered statistical significant.
The number of patients, 22 in each group studied, was
derived on a power calculation based on the assumption
that in the control group, the group receiving the etori-
coxib after surgery would have a mean end-tidal concen-
tration of 1.2 with a standard deviation of 0.23 and that a
reduction of 0.2 would be a clinically significant differ-
ence.
All statistics were made in StatView™ on a Macintosh com-
puter system.
Results
The groups were fully comparative; there was no signifi-
cant difference in patient demographics Table 1. Time
from etoricoxib premedication to start of anaesthesia was
25 (SD 4) minutes.
All surgery and anaesthesia was uneventful and no com-
plications or adverse effects were noticed. One patient in
the etirocoxib group scheduled for arthroscopy had a con-
version to open surgery in order to achieve effect resection
of an exostosis but was still included in the analysis. Dura-
tion of procedures was also the same in both groups;
mean duration of surgery (knife to skin to closed wound)
was 21 (SD 7) minutes.
The mean end-tidal sevoflurane concentration to main-
tain a CSI of 46 (SD 3.9) showed a difference by 0.34% for
the pre and post-operative administered group of patients
respectively (p < 0.0001). No other differences were
noticed intra-operatively; heart rate, blood pressure and
respiratory rate were all well controlled during surgery
and no other major signs of light or excessive anaesthesia
were noticed. No additional analgesics were given during
surgery.
Emergence was rapid and all patients were safely "fast-
tracked", by-passing the regular recovery room, into the
phase II recovery area. Recovery times, time to allowing
drinking and to ambulate were the same in both groups.
In all 6 patients required rescue analgesia during stay in
the recovery area. Five patients in the group receiving etor-
icoxib post-operatively/after surgery and one patient in
the pre-operative group required rescue analgesia before
discharge. No patients complained about nausea during
the stay in the recovery area. Eligible for discharge did not
differ; all patients were discharged home safely within 80
minutes from reaching the phase II recovery area (Table
2).
Five patients were lost for follow-up, 3 in the pre-opera-
tive and 2 in the postoperative etoricoxib group of
patients respectively. No significant difference was
noticed in pain ratings or need for opioid rescue analgesia
during the first 24 postoperative hours. Three patients in
the pre-operative group and 5 in the postoperative group
had at least one opioid rescue during the 24-hour follow-
up period. Four and two patients in the pre and post treat-
ment group respectively experienced PONV following dis-
charge. No difference was seen in "patients' satisfaction"
Table 1: Patient's demographics
Pre-treatment (n = 22) Post-treatment (n = 22)
Sex (male/female) 6/16 11/11
Age (year.) 47 ± 12 42 ± 15
Weight (kg) 80 ± 16 80 ± 15
Surgery
Peroneus ligament 5 7
Fibulo-talar ligament 12 11
Arthroscopy of the ankle 5 4Page 3 of 6
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pain management as satisfactory.
Discussion
Our study is positive; we found a statistical significant dif-
ference between the pre- and post-operative administra-
tion of etoricoxib with regard to our primary study
endpoint; mean end-tidal sevoflurane concentration
needed to maintain a Cerebral State Index of 40–50 dur-
ing elective minor day surgery.
The interpretation of our results should be done with cau-
tion, as the study design is complex. It should indeed be
acknowledged that our patients received a multi-modal
analgesic regime and balanced anaesthesia. All patients
received both betamethasone and alfentanil at induction.
The synergistic interaction between sevoflurane and opio-
ids, reducing the "effective dose 50" (MAC) is well docu-
mented [6]. A clear sevoflurane sparing effect from small
doses of fentanyl in day surgical anaesthesia has been
shown both with and without monitoring of anaesthetic
depth [7]. The main anaesthetic sparing effects of local
anaesthesia is also well recognised [2,3]. We found in an
earlier study, designed similar to the present, a clear effect
from a peripheral local anaesthesia block on the sevoflu-
rane requirement during minor orthopaedic day surgery,
Hallux Valgus surgery [4]. Romunstad et al has also con-
vincingly shown the analgesic properties postoperatively
of steroids [8], improving not only pain but also overall
patient satisfaction. There are no studies, however, docu-
menting any intra-operative effects from the use of ster-
oids. The aim of the present study was to looking at the
potential effect of pre-treatment with a Coxib on the intra-
operative sevoflurane requirement. The mean end-tidal
sevoflurane concentration was statistical significant differ-
ent between the groups studied. No other intra or postop-
erative effects were, however noticed. Intra operative vital
signs did not show any major differences and the
decreased intra-operative anaesthesia requirement did no
translate into any other difference; no significant impact
on emergence time or recovery characteristics was noticed.
Slightly more patients needed rescue analgesia before dis-
charge in the post-administered group of patients. It
should be acknowledge that the number of patients in the
study were limited and based on a power analysis to show
intra-operative effects only. Provision of oral analgesic
shortly after end of anaesthesia may have a slow onset of
action due to delayed enteric absorption contributing to
the differences seen in postoperative rescue analgesia
requirements. The results with regard to postoperative
pain should also take into account that all patients had
etoricoxib either before or right after surgery but also
alfentanil, betamethasone at induction, local anaesthesia
(bupivacaine) at wound closure and a loading dose of 30
mg/kg paracetamol orally at arrival in the phase II recov-
ery area.
The hypothesis of the present study was that adding a
Coxib, etoricoxib, prior to start of surgery would exhibit
not only beneficial effects on the postoperative pain
course but also exhibit intra-operative effects thereby
reducing the need for main anaesthetic. Similar to what
we previously found for local anaesthesia as an ankle
block for Hallux Valgus surgery [4]. Intra-operative effects
of NSAIDs have not been extensively studied. Ding et al
have made two studies comparing ketorlolac to fentanyl
during laparoscopic surgery in general anaesthesia. In the
first study 60 mg ketorolac produced the same intraope-
artive course as fentanyl 50 – 100 microgram [9]. In the
second, they found ketorolac to be inferior to fentanyl in
blunting response to incision, no major difference
between the fentanyl and ketorolac group was seen in
haemodynamic variables [10]. Ramirez-Ruiz et al com-
pared ketorolac with fentanyl for MAC-sedation and in
that setting ketorolac was found less effective as compared
to fentanyl [11]. In another MAC-sedation study, by Yang
et al, ketorolac had a significant fentanyl sparing effect
[12]. Turan et al have also studied the intra-operative
effects of Coxibs [13]. They found preoperative rofecoxib
to have clear intra-operative effects during ENT-surgery in
MAC-sedation.
There are limitations with the present study. The study
design is not double-blinded; still the aim was to achieve
Table 2: Intra and post operative observations
Pre-treatment (n = 22) Post-treatment (n = 22)
Duration of surgery (min.) 21 ± 6 21 ± 7
Propofol (mg/kg) 2.36 ± 0.45 2.41 ± 0.44
Alfentanil μg/kg 0.92 ± 0.09 0.96 ± 0.09
CSI 46 ± 5 46 ± 3
Et Sevo mean (%) 0.909 ± 0.17 1.246 ± 0.23 **
Discharge (min.) 52 ± 5 52 ± 9
Analgesics before discharge (No. of Pat.) 1/21 5/17
** p < 0.0001 ANOVA
Et Sevo; end tidal concentration of sevofluranePage 4 of 6
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by the use of the Cerebral State Index as an objective
measure of anaesthetic depth. The cortical retrieved proc-
essed EEG index describes the balance between stimula-
tion and anaesthetic depth [14] and also the interaction
between analgesia and anaesthetics [7]. One may of
course argue whether the groups were comparable with
regard to depth of anaesthesia. Depth of anaesthesia is not
easily defined. The introduction of EEG, depth-of-anaes-
thesia monitors, has made major change to anaesthetic
practice. These devices make it possible to quantify the
anaesthetic state in real-time on-line. Anaesthetic depth-
monitors have been shown to improve anaesthetic deliv-
ery [15]. We used the Cerebral State Index to quantify
depth of anaesthesia. The CSI has been shown to be more
or less identical to the Bi-spectral index in determining
anaesthetic depth [16,17]. We tried to make the groups as
comparable as possible. We provided induction and anal-
gesics in as standardised doses as possible, however titrat-
ing sevoflurane to maintain the EEG derived depth of
anaesthesia monitoring in a rather narrow pre-defined
range during surgery. A study design quit different from
that of Hirota et al, where a dose of NSAIDs was added to
a steady-state intra-venous anaesthesia without and surgi-
cal stimulation [18]. In disagreement with their hypothe-
sis they could see no change in BIS from the addition of a
conventional non-selective NSAID. It is, however, well
known that BIS as well as CSI are both insensitive to the
effects of certain anaesthetics [19,20].
It is from the present clinical study not possible to make
any comments as to the potential mode of action; in what
way etoricoxib interacts intra-operatively. Further studies
are indeed needed in order to verify our results found in
minor day surgery and to evaluate whether the intra-oper-
ative effects noticed in the present study could translate
into clinical significant benefits, e.g. decrease time for
recovery and decreased incidence and severity of side
effects related to depth of anaesthesia such as postopera-
tive nausea and vomiting, dizziness and fatigue; all factors
of major importance to the ambulatory surgical patient
satisfaction and turn over.
Conclusion
There is today a huge and most reassuring clinical experi-
ence in that NSAIDs/Coxibs have profound effects in
reducing pain, need for opioid rescue analgesia and
improving patients satisfaction when used for postopera-
tive pain management in day surgery. When added to a
multi-modal pain management and provided already pre-
operatively etoricoxib seems to exhibit intra-operative
effects, potentially reducing the need for main anaes-
thetic.
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